A Multi-centre, Phase II, Double-blind, Randomised, Placebo-controlled, Parallel Group, Dose-ranging Study in Patients With Faecal Incontinence; to Evaluate the Efficacy, Safety and Tolerability of Locally Applied NRL001 Over an 8 Week Treatment Period
Clinical trial NCT01656720 · COMPLETED
Trial details
- NCT number
- NCT01656720
- Sponsor
- Norgine
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-01
- Primary completion
- 2013-12-01
- Enrollment
- 417
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.